Endo S2
$0.00 – $840.00
MCLAB’s Endo S2 enzyme is a recombinant endo-β-N-acetylglucosaminidase cloned from Streptococcus pyogenes and expressed in E. coli. This highly specific IgG deglycosylation enzyme hydrolyzes the His-tag core (β-1,4 linkage between two N-acetylglucosamines) of Fc N-linked glycans.
| SKU | Options | Price | Quantity | ||
|---|---|---|---|---|---|
| ENDOS2-100 | Endo S2 (Glycerol-free) (6,000 U) | $210.00 | |||
| ENDOS2-200 | Endo S2 (Glycerol-free) (30,000 U) | $840.00 | |||
| ENDOS2-OEM | Endo S2 (Glycerol-free) (Any Size) | Please inquire | |||
| ENDOS2-100G | Endo S2 (10% Glycerol) (6,000 U) | $210.00 | |||
| ENDOS2-200G | Endo S2 (10% Glycerol) (30,000 U) | $840.00 | |||
| ENDOS2-OEMG | Endo S2 (10% Glycerol) (Any Size) | Please inquire |
- Description
- Documents
- Q&A
Description
Endo S2
• Glycerol-free: Cat# ENDOS2-100, ENDOS2-200, ENDOS2-OEM
• 10% glycerol: Cat# ENDOS2-100G, ENDOS2-200G, ENDOS2-OEMG
Description:
MCLAB’s Endo S2 enzyme is a recombinant endo-β-N-acetylglucosaminidase cloned from Streptococcus pyogenes and expressed in E. coli. This highly specific IgG deglycosylation enzyme hydrolyzes the His-tag core (β-1,4 linkage between two N-acetylglucosamines) of Fc N-linked glycans.
Endo S2 efficiently cleaves:
- High-mannose N-glycans
- Hybrid N-glycans
- Bi-antennary complex N-glycans
- Glycans with or without core fucosylation
The enzyme is widely used in antibody glycosylation analysis, Fc engineering, glycoform remodeling, and biotherapeutic characterization workflows. The enzyme is supplied glycerol-free, making it well suited for HPLC, LC-MS, and other mass spectrometry-intensive workflows.
The enzyme with glycerol as protectant is also available.
Applications:
- IgG Fc deglycosylation
- Antibody glycoengineering
- Glycan remodeling and transfer (oxazoline forms)
- Biotherapeutic development
- Mass spectrometry glycan profiling
- SDS-PAGE mobility shift analysis
Source:
Endo S2 is cloned from Streptococcus pyogenes and recombinantly expressed in E. coli as a fusion protein with a His-tag.
Standard Protocol (Reference)
- Dissolve 1–20 μg glycoprotein in deionized water.
- Add 1 μL 500 mM Tris-HCl (pH 7.5).
- Adjust total volume to 10 μL.
- Add 1–2 μL Endo S2.
- Incubate at 37°C for 60–120 minutes.
- Analyze via SDS-PAGE or mass spectrometry.
Most neutral biological buffers (Tris, PBS) are suitable. Optimization may be required outside neutral pH.
Unit Definition (Standard Assay):
One unit deglycosylates ≥95% of 1 μg human IgG in:
10 mM sodium phosphate
150 mM NaCl
pH 7.4
37°C for 30 minutes
Alternative Activity Definition:
One unit removes >95% carbohydrate from 5 μg human IgG in 1 hour at 37°C (10 μL reaction).
Specific Activity: ≥200,000 U/mL
Additional Activity Measurement:
50% digestion of Cy5-labeled Glycan G2 (0.2 pmol) using 0.2 μg recombinant Endo S2 under assay conditions.
Reagents Supplied with:
Each product configuration includes:
- Endo S2 enzyme (His-tagged)
- 10X Reaction Buffer
Enzyme Concentration: 200,000 units/mL
Storage Buffer for Endo S2 (Glycerol Free) Enzyme
20 mM Tris-HCl
50 mM NaCl
1 mM EDTA
pH 7.5 (25°C)
Storage Buffer for Endo S2 (10% Glycerol) Enzyme
20 mM Tris-HCl
50 mM NaCl
1 mM EDTA
pH 7.5 (25°C)
10% Glycerol
Molecular Weight
Apparent molecular weight: 92 kDa
Related Terms: Endo S2 enzyme, Endo-β-N-acetylglucosaminidase S2, IgG deglycosylation enzyme, Fc glycan removal enzyme, Antibody glycoengineering enzyme, Recombinant Endo S2 protein
Recommended Storage Condition: -20°C, avoid repeated free-thaw
Endo S vs. Endo S2
| ATTRIBUTE | Endo S | Endo S2 |
|---|---|---|
| Enzyme Type | IgG-specific endoglycosidase | Endo-β-N-acetylglucosaminidase S2 |
| Primary Substrate | Native IgG Fc N-glycans | IgG Fc N-glycans + α1-acid glycoprotein |
| Substrate Breadth | IgG-specific | Broader (IgG + non-IgG glycoproteins) |
| Cleavage Site | β-1,4 linkage in chitobiose core of heavy chain | β-1,4 linkage between GlcNAc residues in Fc N-glycans |
| His-Tag (Removable) | YES — Ni-NTA | YES — Ni-NTA |
| Specific Activity | Per unit: >95% removal from 5 μg IgG in 1 hr at 37°C | Stock ≥200,000 U/mL — 1 unit deglycosylates ≥95% of 1 μg IgG in 30 min at 37°C |
| Core Fucosylation Activity | Active (with or without) | Active |
| Bisecting GlcNAc Activity | Active (with or without) | Active |
| Glycerol-Free SKUs | ENDOS-100, ENDOS-200, ENDOS-OEM | ENDOS2-100, ENDOS2-200, ENDOS2-OEM |
| 10% Glycerol SKUs | ENDOS-100G, ENDOS-200G, ENDOS-OEMG | ENDOS2-100G, ENDOS2-200G, ENDOS2-OEMG |
| OEM Quantities | Available | Available |
| Expression Host | E. coli (recombinant) | E. coli (recombinant) |
| Cloned From | Streptococcus pyogenes | Streptococcus pyogenes |
| Storage | -20°C, avoid repeated freeze-thaw | -20°C, avoid repeated freeze-thaw |
| Best For | Standard IgG Fc glycan removal with clean enzyme removal post-reaction | Broader N-glycan analysis, LC-MS, HPLC, ADC synthesis, biotherapeutic characterization |
| Recommended When | Working with native IgG and need clean, removable enzyme | Need broader substrate coverage, HPLC/MS-ready workflow or glycerol-free format |
For Research Use Only
The Q&A for this product will be available soon.

